Exclusive Cooperation between ARTES and the Ukrainian National Academy of Sciences

Langenfeld/Lviv, August 5th, 2009

ARTES announced today that it has signed an exclu­sive Mar­ket­ing Agree­ment with the Insti­tute of Cell Biol­o­gy of the Nation­al Acad­e­my of Sci­ence of Ukraine. Mat­ter of the agree­ment is that the NAS tech­nol­o­gy based on the yeast organ­ism Hansenu­la poly­mor­pha is now exclu­sive­ly mar­ket­ed and licensed by ARTES Biotech­nol­o­gy world­wide except for Ukraine.

The tech­nol­o­gy licensed to ARTES cov­ers new expres­sion tools as well as pro­duc­tion cell lines for var­i­ous prod­ucts, a.o. HepB anti­gen and Arginase. With this agree­ment ARTES expands its Hansenu­la tech­nol­o­gy plat­form and gains access to new process­es and prod­ucts.

With the input from NAS”, said Michael Pio­ntek the man­ag­ing direc­tor from ARTES, “we are now once again able to broad­en up our exper­tise in the Hansenu­la research field. This newest col­lab­o­ra­tion enables us even more to expand our pre­vi­ous offer and espe­cial­ly with the view of East-Euro­pean mar­kets we had won an impor­tant aca­d­e­m­ic research part­ner.”